TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
28.31
+0.39 (1.40%)
At close: Aug 20, 2025, 4:00 PM
28.30
-0.01 (-0.04%)
After-hours: Aug 20, 2025, 7:51 PM EDT
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
$1,343,399
Profits / Employee
$178,870
Market Cap
4.13B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 338 | 74 | 28.03% |
Dec 31, 2023 | 264 | 38 | 16.81% |
Dec 31, 2022 | 226 | -60 | -20.98% |
Dec 31, 2021 | 286 | 14 | 5.15% |
Dec 31, 2020 | 272 | 138 | 102.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TGTX News
- 16 days ago - TG Therapeutics, Inc. (TGTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance - GlobeNewsWire
- 21 days ago - TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update - GlobeNewsWire
- 2 months ago - TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel - Seeking Alpha
- 2 months ago - TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - TG Therapeutics: Estimates Could Soon Be Raised Again - Seeking Alpha
- 3 months ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewsWire
- 3 months ago - TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga